Nemean Asset reports 2.4% stake in Forte Biosciences (FBRX) common stock
Rhea-AI Filing Summary
Forte Biosciences, Inc. received an updated ownership report from investor Steven Michael Oliveira and Nemean Asset Management, LLC. Together they report beneficial ownership of 300,100 shares of Forte Biosciences common stock, representing 2.4% of the outstanding class as of the event date of 01/08/2026. Voting and disposition power over these shares is reported as shared rather than sole.
The filers certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Forte Biosciences, and that they are not participating in any control-related transaction.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Who are the reporting persons in this Forte Biosciences (FBRX) ownership filing?
The reporting persons are Steven Michael Oliveira and Nemean Asset Management, LLC.
Do the reporting persons claim control over Forte Biosciences (FBRX)?
No. They certify the shares were not acquired and are not held to change or influence control of Forte Biosciences.
What is the date of the event that triggered this Forte Biosciences (FBRX) ownership report?
The date of the event requiring the filing is listed as 01/08/2026.